Childhood body mass index and height and risk of histologic subtypes of endometrial cancer

International Journal of Obesity

Volumn 40, Issue 7, 2016, Pages 1096-1102

  Aarestrup, J ^a   Gamborg, M ^a   Ulrich, L G ^b   Sorensen T I A ^a,c   Baker, J L ^a,c  

^a The Capital Region   (Denmark)

^b Rigshospitalet   (Denmark)

^c Capital Region   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ADENOSQUAMOUS CARCINOMA; ADOLESCENT; ADULT; ARTICLE; BODY MASS; BODY SIZE; CANCER RISK; CHILD; CHILDHOOD; CYSTADENOCARCINOMA; DISEASE ASSOCIATION; ENDOMETRIUM CARCINOMA; FEMALE; HEIGHT; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MORPHOLOGY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; VERRUCOUS CARCINOMA; WEIGHT; BODY HEIGHT; BODY WEIGHT; BODY WEIGHT GAIN; CHILDHOOD OBESITY; CLASSIFICATION; COMPLICATION; DENMARK; ENDOMETRIUM TUMOR; MALE; METABOLISM; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR;

ADOLESCENT; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; CHILD; DENMARK; ENDOMETRIAL NEOPLASMS; ESTROGENS; FEMALE; HUMANS; MALE; PEDIATRIC OBESITY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; WEIGHT GAIN;

EID: 84968538086     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2016.56     Document Type: Article

References (41)

1. World Cancer Research Fund/ American Institute for Cancer Research. Continuous Update Project Report. Food, Nutrition, Physical Activity, and the Prevention of Endometrial Cancer, 2015. Available at http://www. dietandcancerreport.org (accessed August 2015)
2. Globocan. Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. International Agency on Cancer (IARC). World Health Organization (WHO), 2015. Available at http://globocan.iarc.fr/ (accessed August 2015)
3. NORDCAN, Association of the Nordic Cancer Registries. (Cancer Statistics), 2015.Available at http://www-dep.iarc.fr/nordcan.htm (accessed August 2015)
4. Aune D, Navarro Rosenblatt DA, Chan DS, Vingeliene S, Abar L, Vieira AR, et al. Anthropometric factors and endometrial cancer risk: a systematic review and dose-response meta-Analysis of prospective studies. Ann Oncol 2015; 26: 1635-1648
5. Bhaskaran K, Douglas I, Forbes H, dos-Santos-Silva I, Leon DA, Smeeth L. Bodymass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet 2014; 384: 755-765
6. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007; 335: 1134
7. McCullough ML, Patel AV, Patel R, Rodriguez C, Feigelson HS, Bandera EV, et al. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype. Cancer Epidemiol Biomarkers Prev 2008; 17: 73-79
8. Arnold M, Pandeya N, Byrnes G, Renehan AG, Stevens GA, Ezzati M, et al. Global burden of cancer attributable to high body-mass index in 2012: a populationbased study. Lancet Oncol 2015; 16: 36-46
9. Horn LC, Meinel A, Handzel R, Einenkel J. Histopathology of endometrial hyperplasia and endometrial carcinoma: an update. Ann Diagn Pathol 2007; 11: 297-311
10. Yang HP, Wentzensen N, Trabert B, Gierach GL, Felix AS, Gunter MJ, et al. Endometrial cancer risk factors by 2 main histologic subtypes: the NIH-AARP diet and health Study. Am J Epidemiol 2013; 177: 142-151
11. Felix AS, Weissfeld JL, Stone RA, Bowser R, Chivukula M, Edwards RP, et al. Factors associated with Type I and Type II endometrial cancer. Cancer Causes Control 2010; 21: 1851-1856
12. Danish Gynecological Cancer Group. Danish Gynecological Cancer Database National Annual Report 2013/2014: Nationwide Clinical Database for Cancer of the Ovaries, Uterus and Cervix [Dansk Gynækologisk Cancer Database National Årsrapport 2013/2014: Landsdækkende klinisk database for kræft i æggestokke, livmoder og livmoderhals], 2015. Available at http://www.dgcg.dk/images/rsrap port-DGCD-2013-14-endelig%20version.pdf (accessed August 2015)
13. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 2002; 11: 1531-1543
14. Green J, Cairns BJ, Casabonne D, Wright FL, Reeves G, Beral V. Height and cancer incidence in the Million Women Study: prospective cohort, and meta-Analysis of prospective studies of height and total cancer risk. Lancet Oncol 2011; 12: 785-794
15. Blitzer PH, Blitzer EC, Rimm AA. Association between teen-Age obesity and cancer in 56, 111 women: all cancers and endometrial carcinoma. Prev Med 1976; 5: 20-31
16. Chang SC, Lacey Jr. JV, Brinton LA, Hartge P, Adams K, Mouw T, et al. Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev 2007; 16: 723-730
17. Dal ML, Tavani A, Zucchetto A, Montella M, Ferraroni M, Negri E, et al. Anthropometric measures at different ages and endometrial cancer risk. Br J Cancer 2011; 104: 1207-1213
18. Henderson BE, Casagrande JT, Pike MC, Mack T, Rosario I, Duke A. The epidemiology of endometrial cancer in young women. Br J Cancer 1983; 47: 749-756
19. Le Marchand L, Wilkens LR, Mi MP. Early-Age body size, adult weight gain and endometrial cancer risk. Int J Cancer 1991; 48: 807-811
20. Olson SH, Trevisan M, Marshall JR, Graham S, Zielezny M, Vena JE, et al. Body mass index, weight gain, and risk of endometrial cancer. Nutr Cancer 1995; 23: 141-149
21. Swanson CA, Potischman N, Wilbanks GD, Twiggs LB, Mortel R, Berman ML, et al. Relation of endometrial cancer risk to past and contemporary body size and body fat distribution. Cancer Epidemiol Biomarkers Prev 1993; 2: 321-327
22. Weiderpass E, Persson I, Adami HO, Magnusson C, Lindgren A, Baron JA. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 2000; 11: 185-192
23. Xu WH, Xiang YB, Zheng W, Zhang X, Ruan ZX, Cheng JR, et al. Weight history and risk of endometrial cancer among Chinese women. Int J Epidemiol 2006; 35: 159-166
24. Yang TY, Cairns BJ, Allen N, Sweetland S, Reeves GK, Beral V. Postmenopausal endometrial cancer risk and body size in early life and middle age: prospective cohort study. Br J Cancer 2012; 107: 169-175
25. Baker JL, Olsen LW, Andersen I, Pearson S, Hansen B, Sørensen TIA. Cohort profile: the Copenhagen School Health Records Register. Int J Epidemiol 2009; 38: 656-662
26. Pedersen CB. The Danish Civil Registration System. Scand J Public Health 2011; 39: 22-25
27. Cole TJ, Green PJ. Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med 1992; 11: 1305-1319
28. Baker JL, Olsen LW, Sørensen TIA. Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med 2007; 357: 2329-2337
29. Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health 2011; 39: 42-45
30. Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registryhistory, content, quality and use. Dan Med Bull 1997; 44: 535-539
31. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health 2011; 39: 30-33
32. Kildemoes HW, Sorensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health 2011; 39: 38-41
33. Renehan AG, Soerjomataram I, Tyson M, Egger M, Zwahlen M, Coebergh JW, et al. Incident cancer burden attributable to excess body mass index in 30 European countries. Int J Cancer 2010; 126: 692-702
34. Crosbie EJ, Zwahlen M, Kitchener HC, Egger M, Renehan AG. Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-Analysis. Cancer Epidemiol Biomarkers Prev 2010; 19: 3119-3130
35. Bjørge T, Engeland A, Tretli S, Weiderpass E. Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. Int J Cancer 2007; 120: 378-383
36. Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang YB, et al. Type I and II endometrial cancers: have they different risk factors?. J Clin Oncol 2013; 31: 2607-2618
37. Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D. Hormone replacement therapy and endometrial cancer risk: a meta-Analysis. Obstet Gynecol 1995; 85: 304-313
38. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4: 579-591
39. Power C, Lake JK, Cole TJ. Body mass index and height from childhood to adulthood in the 1958 British born cohort. Am J Clin Nutr 1997; 66: 1094-1101
40. Purdie DM, Green AC. Epidemiology of endometrial cancer. Best Pract Res Clin Obstet Gynaecol 2001; 15: 341-354
41. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014; 311: 806-814